PharmaShots | Incisive News in 3 Shots

Subscribe Now

US.FDA

Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly Dosing

Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly Dosing

September 17, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us